2,259 Shares in Colgate-Palmolive (NYSE:CL) Purchased by SYM FINANCIAL Corp

SYM FINANCIAL Corp acquired a new stake in shares of Colgate-Palmolive (NYSE:CLFree Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 2,259 shares of the company’s stock, valued at approximately $235,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Acadian Asset Management LLC grew its holdings in shares of Colgate-Palmolive by 108.4% during the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after buying an additional 2,955,442 shares in the last quarter. FMR LLC boosted its position in Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after acquiring an additional 2,674,807 shares during the period. Massachusetts Financial Services Co. MA grew its stake in Colgate-Palmolive by 40.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock valued at $870,400,000 after acquiring an additional 2,593,313 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of Colgate-Palmolive by 58.6% in the second quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company’s stock worth $234,540,000 after purchasing an additional 892,706 shares in the last quarter. Finally, Canada Pension Plan Investment Board boosted its holdings in shares of Colgate-Palmolive by 38.8% during the second quarter. Canada Pension Plan Investment Board now owns 2,541,975 shares of the company’s stock worth $246,673,000 after purchasing an additional 710,500 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

NYSE CL opened at $95.10 on Friday. The stock has a market capitalization of $77.70 billion, a PE ratio of 27.25, a P/E/G ratio of 3.38 and a beta of 0.43. The stock has a 50-day simple moving average of $96.73 and a 200 day simple moving average of $98.61. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a twelve month low of $75.50 and a twelve month high of $109.30.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $0.50 dividend. The ex-dividend date was Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.10%. Colgate-Palmolive’s dividend payout ratio is 57.31%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research note on Monday, October 28th. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price objective for the company from $105.00 to $101.00 in a research report on Monday, October 28th. JPMorgan Chase & Co. upped their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Finally, StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday, November 25th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $105.11.

Check Out Our Latest Analysis on CL

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.